Super El Nino could strain India's disease surveillance, healthcare infrastructure and pharmaceutical supply chains as climate-linked health risks rise.
WHO’s new ten-year agenda puts traditional medicine under a stronger evidence test, focusing research on high-burden diseases, safety, and healthcare integration.
India is building a wider safety net for transplant medicines with a dedicated Biovigilance Programme to strengthen adverse-event monitoring and patient safety.
Congo's Ebola vaccination drive is testing how quickly pharma can turn vaccine research into real-world outbreak protection.
September has emerged as the worst month for dengue in Delhi this year, with the Municipal Corporation of Delhi reporting 121 cases so far.
India’s proposed easier drug rules could help pharma companies shorten development timelines, accelerate generic launches, and improve access to affordable medicines.
India’s race to eliminate cervical cancer gains momentum as HPV vaccination crosses 80 lakh doses, strengthening the country’s prevention efforts.
Centre’s HPV drive comes under watch as a PIL seeks Supreme Court intervention over consent, safety, and accountability.
As swine flu cases climb, Uttar Pradesh moves to make government hospital testing free and strengthens surveillance across the state.
Swine flu concerns are spreading from Delhi to Agra as Uttar Pradesh steps up surveillance, screening and hospital preparedness to track H1N1 cases.
.jpg)
, CDSCO.jpg)